| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/16/1996 | US5508030 Creating new capillary blood pools for practicing bidirectional medicine |
| 04/15/1996 | CA2118149A1 Composition and method of treating hepatitis b |
| 04/11/1996 | WO1996010639A2 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION AND GASTRIC CARCINOMA |
| 04/11/1996 | WO1996010638A1 Alpha-1-antitrypsin and antithrombine-iii variants |
| 04/11/1996 | WO1996010636A1 Novel compounds useful for preparing anti-infective agents |
| 04/11/1996 | WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof |
| 04/11/1996 | WO1996010629A1 The irs family of genes |
| 04/11/1996 | WO1996010584A1 Process for extracting high-purity von willebrand factor |
| 04/11/1996 | WO1996010579A1 Blocking expression of virulence factors in s. aureus |
| 04/11/1996 | WO1996010577A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 04/11/1996 | WO1996010424A1 Cellular immunity-inducing conjugate |
| 04/11/1996 | WO1996010421A1 Vaccine compositions |
| 04/11/1996 | WO1996010419A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 04/11/1996 | WO1996010418A1 Human monocyte elastase inhibitor |
| 04/11/1996 | WO1996010417A1 PREPARATIONS CONTAINING AspB28 HUMAN INSULIN AND NICOTINAMIDE |
| 04/11/1996 | WO1996010416A1 DRUGS CONTAINING β-INTERFERON |
| 04/11/1996 | WO1996010415A1 Preparation of mhc-peptide complexes |
| 04/11/1996 | WO1996010414A1 Trophinin and trophinin-assisting proteins |
| 04/11/1996 | WO1996010413A1 Compositions containing tumor rejection antigen precursors or tumor rejection antigens, and an adjuvant and/or growth factor |
| 04/11/1996 | WO1996010412A1 Use of human chorionic gonadotropin as an immune-potentiating agent |
| 04/11/1996 | WO1996010411A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 04/11/1996 | WO1996010402A1 Multi-faceted method to repress reproduction of latent viruses in humans and animals |
| 04/11/1996 | WO1996010401A1 Methods for regulation of insulin-like growth factor i receptor |
| 04/11/1996 | WO1996010395A1 Controlled-release pharmaceutical preparations |
| 04/11/1996 | WO1996007421A3 An antiulcer medicine comprising a protein possessing all growth factor activity and a proton pump inhibitor |
| 04/11/1996 | WO1996005866A3 Live vaccine for the treatment of tumour diseases |
| 04/11/1996 | WO1996005854A3 Combination preparation, containing cyclosporin a or fk506 or rapamycin and a xanthine derivative |
| 04/11/1996 | WO1996005838A3 Combined preparation for the therapy of immune diseases |
| 04/11/1996 | WO1996005797A3 Agent for external application with nutrient and protective properties |
| 04/11/1996 | DE4436164A1 New conjugates of tetra:carbohydrate and amide-linked peptide or dye etc. |
| 04/11/1996 | DE4435907A1 Recombinant papilloma virus-like particles contg. L1 or L2 proteins |
| 04/11/1996 | DE4435805A1 Zweikomponenten-Creme Two-cream |
| 04/11/1996 | DE4435661A1 Mittel zur Behandlung von Papillomvirus-positiven gutartigen, malignen und prämalignen Läsionen Agents for the treatment of papilloma virus-positive benign, malignant and pre-malignant lesions |
| 04/11/1996 | CA2201519A1 Preparation of mhc-peptide complexes |
| 04/11/1996 | CA2201498A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 04/11/1996 | CA2201474A1 The irs family of genes |
| 04/11/1996 | CA2201353A1 The taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
| 04/11/1996 | CA2201327A1 Compositions containing tumor rejection antigen precursors or tumor rejection antigens, and an adjuvant and/or growth factor |
| 04/11/1996 | CA2201119A1 Trophinin and trophinin-assisting proteins |
| 04/11/1996 | CA2199154A1 The use of medicaments containing interferon-beta |
| 04/11/1996 | CA2160100A1 Carbohydrate conjugates as inhibitors of cell adhesion |
| 04/10/1996 | EP0705903A1 In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene |
| 04/10/1996 | EP0705902A1 17q-Linked breast and ovarian cancer susceptibility gene |
| 04/10/1996 | EP0705901A2 Method of separating recombinant pro-factor IX from recombinant factor IX |
| 04/10/1996 | EP0705846A1 High molecular weight and low molecular weight fractions of von Willebrand factor |
| 04/10/1996 | EP0705844A1 Gene encoding cationic amino acid transporter protein |
| 04/10/1996 | EP0705842A2 Regulated genes by stimulation of chondrocytes with 1L-1beta |
| 04/10/1996 | EP0705841A1 Peptides havng antigenic activity against hepatitis A virus (HAV) |
| 04/10/1996 | EP0705603A1 Use of non-toxic cysteine sulfoxide derivatives in the treatment of cancer or for enhancing the T-cell count |
| 04/10/1996 | EP0705435A1 A novel family of pollen proteinases, methods of use thereof and compositions derived therefrom |
| 04/10/1996 | EP0705433A1 Compositions and methods for anti-addictive narcotic analgesis acivity screening and treatments |
| 04/10/1996 | EP0705346A1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
| 04/10/1996 | EP0705341A1 Hybrid receptor molecules |
| 04/10/1996 | EP0705339A1 Human cell adhesion protein aamp-1 and uses thereof |
| 04/10/1996 | EP0705332A1 Construction and use of synthetic constructs encoding syndecan |
| 04/10/1996 | EP0705278A1 Apoptose inhibitor |
| 04/10/1996 | EP0705276A1 Prostaglandin receptor fp and dna encoding it |
| 04/10/1996 | EP0705275A1 Asp?b28 insulin crystals |
| 04/10/1996 | EP0705274A1 Method and composition for treating thrombosis |
| 04/10/1996 | EP0705244A1 Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system |
| 04/10/1996 | EP0705110A1 Immunoglobulin infusion in xenotransplantation |
| 04/10/1996 | EP0705107A1 Interleukin-2 stimulated t lymphocyte cell death for the treatment of autoimmune diseases, allergic disorders, and graft rejection |
| 04/10/1996 | EP0705106A1 Treatment of automatic nerve dysfunction with botulinum toxin |
| 04/10/1996 | EP0705104A1 Method of cancer treatment |
| 04/10/1996 | EP0705098A1 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders |
| 04/10/1996 | EP0547079B1 New use of a monoclonal antibody |
| 04/10/1996 | EP0537148B1 Purification of human interleukin-4 secreted from an escherichia coli mutant |
| 04/10/1996 | EP0507870B1 Polyhemoglobin stabilized by purine derivatives and glutathione |
| 04/10/1996 | EP0450095B1 Method of assaying d-vanillylmandelic acid, and reagent and kit therefor |
| 04/10/1996 | EP0448697B1 Vitamin a analogues and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
| 04/10/1996 | EP0387286B1 Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes |
| 04/10/1996 | CN1120352A Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 04/10/1996 | CN1120351A An alpha-galactosidase enzyme |
| 04/10/1996 | CN1120070A Point pallas pit viper poisonous fibre-dissolving enzyme and its purifying method |
| 04/10/1996 | CN1120047A New peptide compound and a process for the preparation thereof |
| 04/10/1996 | CN1120040A Identification and use of protease inhibitors |
| 04/10/1996 | CN1119955A An antihypoxic formulation |
| 04/09/1996 | US5506343 Antibodies specific for the DF3 carcinoma associated antigen |
| 04/09/1996 | US5506342 Chemical reduction, crosslinking, chelating, cleaving and stabilizing |
| 04/09/1996 | US5506341 Improving the therapeutic activity by incubating with buffer at neutral condition |
| 04/09/1996 | US5506340 Tumor necrosis factor inhibitors |
| 04/09/1996 | US5506339 Octapeptide analogs of somatostatin having threonine at the sixth position |
| 04/09/1996 | US5506267 Thioglycerol derivatives |
| 04/09/1996 | US5506258 Exhibit affinity for the biological receptors of neuropeptides y, which are present in the central and peripheral nervous systems |
| 04/09/1996 | US5506244 Treating cardiovascular disorders |
| 04/09/1996 | US5506231 Administering an antagonist of excitatory amino acids to reduce central nervous system disorder caused by human immunodeficiency virus infection |
| 04/09/1996 | US5506229 Skeletal and muscle disorders |
| 04/09/1996 | US5506228 2,6-diaryl pyridazinones with immunosuppressant activity |
| 04/09/1996 | US5506218 Intravenously administering a protein and peptide free phospholipid and neutral lipid to the subject; prophylaxis |
| 04/09/1996 | US5506209 Product for inhibition of infection of mammalian cells by respiratory syncytial virus |
| 04/09/1996 | US5506208 Method for using synthetic analogs of thrombospondin for inhibiting angiogenesis activity |
| 04/09/1996 | US5506207 GNRH antagonists XIII |
| 04/09/1996 | US5506206 Arginine-proline-hydroxyproline-glycine-thienylalanine-serine -(4-methyl-tyrosine)-arganine or a conformational analogue, used as therapeutical or diagnostic agents |
| 04/09/1996 | US5506205 Treatment of diabetes |
| 04/09/1996 | US5506204 Muramyl compounds for treatment of septic shock |
| 04/09/1996 | US5506203 Systemic administration of a therapeutic preparation |
| 04/09/1996 | US5506202 Insulin derivatives, a process for the preparation thereof, the use thereof, and a pharmaceutical formulation containing them |
| 04/09/1996 | US5506135 Fab fragment, having specificities against fibrin and thrombolytic substances |
| 04/09/1996 | US5506134 Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex |
| 04/09/1996 | US5506133 Polypeptide |